Universal Ibogaine Inc Cash Flow Conversion Efficiency
Universal Ibogaine Inc cash flow conversion efficiency. Based on the latest financial reports, Universal Ibogaine Inc (IBO) has a cash flow conversion efficiency ratio of -0.405x as of April 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-110.36K ≈ $-79.84K USD) by net assets (CA$272.17K ≈ $196.89K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Universal Ibogaine Inc (2018–2024)
Cash flow conversion efficiency of Universal Ibogaine Inc from 2018 to 2024. This chart illustrates how Universal Ibogaine Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Universal Ibogaine Inc (IBO) share price today for real-time trading data and today's change.
Universal Ibogaine Inc Cash Flow Conversion Ratio Explained
Universal Ibogaine Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Universal Ibogaine Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Universal Ibogaine Inc ranked by their cash flow conversion efficiency. Also see Universal Ibogaine Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ambipar Emergency Response
NYSE:AMBIQ
|
0.074x |
|
2cureX AB
ST:2CUREX
|
3.288x |
|
BEACN Wizardry & Magic Inc
V:BECN
|
0.886x |
|
Starbox Group Holdings Ltd. Ordinary Shares
NASDAQ:STBX
|
-0.001x |
|
Altiplano Metals Inc
V:APN
|
3.221x |
|
Baring Emerging Europe Plc
LSE:BEMO
|
0.014x |
|
Handal Resources Bhd
KLSE:7253
|
0.089x |
|
Onfolio Holdings Inc
NASDAQ:ONFO
|
0.337x |
Annual Cash Flow Conversion Efficiency for Universal Ibogaine Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Universal Ibogaine Inc from 2018 to 2024. Review IBO FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-07-31 | CA$991.11K ≈ $716.95K |
CA$-838.61K ≈ $-606.64K |
-0.846x | -35.07% |
| 2023-07-31 | CA$1.75 Million ≈ $1.27 Million |
CA$-1.10 Million ≈ $-793.82K |
-0.626x | +43.00% |
| 2022-07-31 | CA$3.94 Million ≈ $2.85 Million |
CA$-4.33 Million ≈ $-3.13 Million |
-1.099x | -100.15% |
| 2021-07-31 | CA$-4.46K ≈ $-3.22K |
CA$-3.25 Million ≈ $-2.35 Million |
729.129x | +3068.20% |
| 2020-07-31 | CA$94.89K ≈ $68.64K |
CA$-2.33 Million ≈ $-1.69 Million |
-24.565x | -433.93% |
| 2019-07-31 | CA$197.12K ≈ $142.59K |
CA$-906.88K ≈ $-656.02K |
-4.601x | -324.00% |
| 2018-07-31 | CA$295.22K ≈ $213.56K |
CA$-320.34K ≈ $-231.73K |
-1.085x | -- |
About Universal Ibogaine Inc
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.